BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1785000)

  • 1. Integral photodynamic therapy of superficial bladder tumors with special reference to carcinoma in situ.
    Hisazumi H; Naito K; Uchibayashi T; Hirata A; Komatsu K
    Scand J Urol Nephrol Suppl; 1991; 138():161-5. PubMed ID: 1785000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integral laser photodynamic treatment of refractory multifocal bladder tumors.
    Naito K; Hisazumi H; Uchibayashi T; Amano T; Hirata A; Komatsu K; Ishida T; Miyoshi N
    J Urol; 1991 Dec; 146(6):1541-5. PubMed ID: 1942336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Photodynamic therapy of superficial tumors and carcinoma in situ of the bladder].
    Hisazumi H; Ueki O; Kumaki O; Naito K; Misaki T
    Gan No Rinsho; 1985 May; 31(6 Suppl):697-703. PubMed ID: 4032754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Photodynamic therapy of superficial bladder tumors].
    Misaki T; Hisazumi H; Hirata A; Kunimi K; Yamamoto H; Amano T; Kumaki O; Koshida K; Nishino A; Nakazima K
    Hinyokika Kiyo; 1986 Dec; 32(12):1941-8. PubMed ID: 3825831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improved argon laser photodynamic therapy for superficial bladder tumor--experimental research and clinical analysis].
    Guo YC
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):75-7. PubMed ID: 2142071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder.
    Prout GR; Lin CW; Benson R; Nseyo UO; Daly JJ; Griffin PP; Kinsey J; Tian ME; Lao YH; Mian YZ
    N Engl J Med; 1987 Nov; 317(20):1251-5. PubMed ID: 2959863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Photodynamic therapy with hematoporphyrin derivative for transitional-cell carcinoma of the urinary bladder--report of 30 cases].
    Tian ME
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):304-6. PubMed ID: 2533889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy.
    Nseyo UO
    Urol Clin North Am; 1992 Aug; 19(3):591-9. PubMed ID: 1386168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial manufacture of a motor-driven laser light scattering optic for whole bladder wall irradiation.
    Hisazumi H; Miyoshi N; Misaki T
    Prog Clin Biol Res; 1984; 170():239-47. PubMed ID: 6241679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor recurrence prevention using photodynamic therapy after treatment of bladder cancer].
    Sun X; Li H; Wang M
    Zhonghua Wai Ke Za Zhi; 1995 Mar; 33(3):179-80. PubMed ID: 7555391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo.
    Bellnier DA; Prout GR; Lin CW
    J Natl Cancer Inst; 1985 Mar; 74(3):617-25. PubMed ID: 3856065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of photodynamic therapy in the treatment of refractory carcinoma in situ].
    Benson RC
    Urologe A; 1991 May; 30(3):158-61; discussion 161-2. PubMed ID: 1871933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of bladder cancer by Nd:YAG laser local irradiation and whole-bladder photodynamic therapy with hematoporphyrin derivative].
    Li CL; Xu BZ; Shong XY
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):458-60. PubMed ID: 7720506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy.
    Benson RC; Kinsey JH; Cortese DA; Farrow GM; Utz DC
    J Urol; 1983 Dec; 130(6):1090-5. PubMed ID: 6227755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Integral photodynamic therapy of multifocal bladder cancer. Initial clinical experiences].
    Jocham D; Staehler G; Baumgartner R; Unsöld E
    Urologe A; 1985 Nov; 24(6):316-9. PubMed ID: 4090126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy Tis and T1 transitional carcinoma of the bladder.
    Javadpour N
    Prog Clin Biol Res; 1989; 303():471-8. PubMed ID: 2780658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Whole bladder wall laser irradiation to prevent bladder cancer recurrence with intravesical HpD and ascorbic acid].
    Li C; Chen Y; Wang Q
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):463-5. PubMed ID: 10920885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.